Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Curelab Oncology

Clinical trials sponsored by Curelab Oncology, explained in plain language.

Can a DNA-Based therapy revive Chemotherapy's power against resistant ovarian cancer?

Disease control Completed

This phase 2 trial is investigating whether adding an experimental DNA-based therapy called ELENAGEN to the chemotherapy drug gemcitabine can help people with platinum-resistant ovarian cancer. The study will compare the combination against gemcitabine alone, measuring how long p…

Phase 2 • Sponsor: CureLab Oncology • Aim: Disease control

Last updated Aug 26, 2026 00:00 UTC